Company Filing History:
Years Active: 2021-2022
Title: Yung-Ning Yang: Innovator in Amide Compounds
Introduction
Yung-Ning Yang is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of amide compounds. With a total of 2 patents to his name, Yang's work focuses on innovative solutions for treating glucagon-associated disorders.
Latest Patents
Yang's latest patents include groundbreaking research on amide compounds and their applications. The first patent discloses compounds of formula (I) and pharmaceutically acceptable salts thereof. It outlines methods for reducing glycemic levels and treating glucagon-associated disorders using these compounds. The second patent also focuses on amide compounds, detailing similar methods and applications for managing glycemic levels and related health issues.
Career Highlights
Yang is currently associated with Alphala Co., Ltd., where he continues to push the boundaries of pharmaceutical innovation. His work has garnered attention for its potential impact on health and medicine, particularly in managing diabetes and related conditions.
Collaborations
Yang collaborates with notable colleagues, including Cheng-Ho Chung and Shi-Liang Tseng. Their combined expertise enhances the research and development efforts at Alphala Co., Ltd.
Conclusion
Yung-Ning Yang's contributions to the field of pharmaceuticals through his innovative patents on amide compounds highlight his role as a key inventor in the industry. His work promises to advance treatment options for glucagon-associated disorders, showcasing the importance of innovation in healthcare.